This is a regulatory disclosure made by Emcure Pharmaceuticals Limited to the National Stock Exchange of India Limited and BSE Limited, in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Nature of the Event
The company has allotted equity shares to its employees upon the exercise of vested stock options.
Key Quantitative Figures and Allotment Details
- Number of Shares Allotted: 19,100 (Nineteen Thousand One Hundred)
- Face Value per Share: Rs. 10/- (Rupees Ten only)
- Scheme: Allotment was made pursuant to the Emcure - Employee Stock Option Scheme 2013 (Emcure ESOS 2013).
- Vested Options Exercised: 19,100
Approval Details
- Approving Authority: The Nomination and Remuneration Committee of the Board of Directors of the Company.
- Approval Method: Resolution by Circulation (No. 03 of 2026-27).
- Approval Date: August 25, 2026.
Capital Structure Impact
Consequent to the allotment, the issued and paid-up share capital of the Company has increased as follows:
| | From | To |
| Number of Equity Shares | 18,96,80,147 | 18,96,99,247 |
| Aggregate Value | Rs. 1,89,68,01,470/- | Rs. 1,89,69,92,470/- |
Rights of the Allotted Shares
The newly allotted 19,100 equity shares will rank pari passu in all aspects with the existing equity shares of the company.